Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43 Grant US-11965033-B2 United States of America 23 Apr 2024
COMPOSITIONS AND METHODS FOR REDUCING OFF-TARGET TOXICITY OF ANTIBODY DRUG CONJUGATES Application EP-4069312-A4 European Patent Office 27 Mar 2024
METHODS FOR TREATMENT OF CD20-POSITIVE PROLIFERATIVE DISORDER WITH MOSUNETUZUMAB AND… Application US-20220411528-A1 United States of America 29 Dec 2022
Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43 Grant US-11174318-B2 United States of America 16 Nov 2021